跳至主要内容
临床试验/EUCTR2018-003047-32-IT
EUCTR2018-003047-32-IT进行中(未招募)1 期

CardioPulmonary resuscitation with Argon (CPAr) trial - CPAR Trial

IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI0 个研究点目标入组 50 人开始时间: 2021年5月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) witnessed non-traumatic OHCA of presumably cardiac etiology with a presenting shockable rhythm; (2) age = 18 years; (3) unconsciousness after return of spontaneous circulation (ROSC); (4) duration of CPR = 30 mins; (5) initiation of study intervention = 3 hrs from ROSC; (6) stable SaO2 = 94%, with a FiO2 of 30%.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • (1) age < 18 years; (2) non-witnessed CA; (3) CA of traumatic origin; (4) non-presumably cardiac cause; (5) non-shockable presenting rhythm (pulseless electrical activity and asystole); (6) pregnancy; (7) known terminal illness; (8) pre-CA cerebral performance category (CPC) = 3; (9) initiation of the study intervention > 3 hrs from ROSC; (10) partecipation to another clinical trial;

研究者

发起方
IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

相似试验